stockrow
Friday 6 November 2026
Export MMED’s income statement to Excel — free account
MiniMed Group, Inc.
MMED Healthcare Medical Instruments & Supplies
MiniMed Group, Inc.’s revenue for fiscal 2026 (year ended April 2026) was $3.1 billion, up 14.3% from fiscal 2025.
18.23
1.06
−5.50%
Follow MMED
Alert me
MiniMed Group, Inc. (MMED) Free cash flow margin
MiniMed Group, Inc.'s free cash flow margin over the twelve months to 31 July 2026 was −14.9%, down 1.3 percentage points from fiscal 2026 (−13.5%). That is below the Medical Instruments & Supplies industry median of 2.36% and below the Healthcare sector median of 0.00%.
Free cash flow margin, annual
Embed this chart
Annual newest first
| Period | Free cash flow margin | Change (points) |
|---|---|---|
| FY2026 | −13.5% | (11.59) |
| FY2025 | −1.95% | 2.38 |
| FY2024 | −4.33% | — |
Free cash flow margin against peers
| Company | Free cash flow margin |
|---|---|
| MMSI Merit Medical Systems, Inc. compare | 14.0% |
| ICUI ICU Medical, Inc. compare | 12.5% |
| ATRC AtriCure, Inc. compare | 8.98% |
| NVST Envista Holdings Corporation compare | 8.50% |
| BLCO Bausch + Lomb Corporation compare | 4.65% |
| TFX Teleflex Incorporated compare | 2.36% |
| STVN Stevanato Group S.p.A. compare | −0.61% |
| MMED MiniMed Group, Inc. | −14.9% |
| PLSE Pulse Biosciences, Inc compare | −14,462.5% |
| Medical Instruments & Supplies industry median | 2.36% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Free cash flow margin is
Free Cash Flow Margin tells an investor how much of each sale turns into cash the company keeps after paying for investment in its assets.
(Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)) ÷ Revenue
More on MMED
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Shares outstanding
- Book value per share
- The full statement